4 days ago
Government Revives Pharma Logistics Study to Map Future Needs
The government wants to understand how medicines and medical devices move from factories to customers.
It has restarted a study and issued a new tender.
The study will look at roads, storage, cold rooms, customs and delivery times.
It will cover products used in the country and products sent abroad.
The consultant will decide which problems deserve the most attention.
The study will also estimate what infrastructure may be needed during the next 10 years.
It may suggest using artificial intelligence and blockchain to track shipments.
One consultant or a group of up to three companies will complete the work in six months.
The Department of Pharmaceuticals has issued a revised tender for a pharma and medical-device logistics study.
The consultant will identify priority areas independently rather than follow government-prescribed focus areas.
The study will examine logistics costs, transit times, infrastructure, cold chains, customs and multimodal connectivity.
It will cover domestic and export value chains, including raw materials, APIs, diagnostics and last-mile delivery.
One consultant, including a consortium of up to three entities, will have six months to complete the study.
- Who
- The Department of Pharmaceuticals will appoint one consultant, potentially a consortium or joint venture of up to three entities.
- What
- A revised tender seeks a study of pharma and medical-device logistics infrastructure, supply chains, regulations and future capacity needs.
- Where
- The study will cover domestic and export value chains, including logistics from raw-material sourcing to last-mile delivery.
- When
- The consultant will have six months to complete the study; the articles do not specify the study’s start date.
- Why
- The government wants to identify infrastructure and policy gaps, guide investment and reduce delays and logistics costs.
Key facts
- Commissioning agency
- Department of Pharmaceuticals
- Planning horizon
- The next 10 years
- Scope
- Pharmaceuticals and medical devices, including APIs and diagnostics
- Areas assessed
- Transport, storage, cold chains, customs and multimodal connectivity
- Technology focus
- Artificial intelligence and blockchain for logistics and tracking
- Consultant structure
- One consultant; a consortium or joint venture may include up to three entities
- Completion period
- Six months
Quotes
Official of a pharma association
Representative of a pharmaceutical industry association
“If implemented, the plan could give the government a clearer basis for deciding where logistics investments are needed. It could also help set practical targets for reducing delays in the movement of pharma and medical device products”
financialexpress.com
“The study could also guide future investments in facilities such as cold chains and logistics parks, based on actual industry demand and location needs”
financialexpress.com
The revised request for proposal
Government tender document outlining the study requirements
“There are no pre-defined non-negotiable focus areas. The consultant is expected to identify priority areas based on analysis”
financialexpress.com
Sources
Related news
India Develops Warehouse, Cold Chain Standards With ADB
Noida Airport, Dadri Proposed Among Ten New Drug Gateways
Freight Corridors and Logistics Parks Could Cut India’s Costs
Logistics Firms Prepare for a More Complex Festive Season
Mohan Yadav Courts Dubai Investment in Logistics, Energy, Technology
Balmer Lawrie Plans ₹500 Crore Logistics Expansion Over Three Years
CCPA Fines Amazon, Flipkart and JioMart Over Unregistered Herbicide
Pharma PLI Draws Record Investment, But China Import Dependence Persists
Maharashtra FDA Flags Huge Markups on Hospital Consumables
Medical Device Industry Seeks Overhaul of Pricing Rules
